I knew that $25, $26, $27, $28 & $29 were resistance
You keep spouting that same lie about no acquisitions in analysts' estimates even though I've seen at least three posts here proving this baseless assertion false.
Why do you lie?
2012 will certainly be lower than 2011 if Lipitor patent gets extended. Also, that year has its own big expirations.
The current consensus of analysts' estimates for 2012 is $2.01, with 2/3 of them including all possible "additive factors", but unlike your raving lunatic blathering, real analysts also factor in probable & possible negatives.